These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14607508)

  • 1. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel.
    Fujita M; Ishihara M; Simizu M; Obara K; Ishizuka T; Saito Y; Yura H; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Biomaterials; 2004 Feb; 25(4):699-706. PubMed ID: 14607508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
    J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
    Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
    Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
    J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
    Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
    J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
    Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
    Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
    Ishihara M; Obara K; Nakamura S; Fujita M; Masuoka K; Kanatani Y; Takase B; Hattori H; Morimoto Y; Ishihara M; Maehara T; Kikuchi M
    J Artif Organs; 2006; 9(1):8-16. PubMed ID: 16614797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice.
    Obara K; Ishihara M; Ishizuka T; Fujita M; Ozeki Y; Maehara T; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
    Biomaterials; 2003 Sep; 24(20):3437-44. PubMed ID: 12809772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities.
    Tabata Y; Ikada Y
    Biomaterials; 1999 Nov; 20(22):2169-75. PubMed ID: 10555085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
    Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
    Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
    Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
    J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
    Matsui M; Tabata Y
    Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis.
    Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X
    Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
    S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
    Yoon JJ; Chung HJ; Park TG
    J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascularization around poly(tetrafluoroethylene) mesh with coating of gelatin hydrogel incorporating basic fibroblast growth factor.
    Takaoka R; Hikasa Y; Tabata Y
    J Biomater Sci Polym Ed; 2009; 20(10):1483-94. PubMed ID: 19622284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.
    Fan Z; Xu Z; Niu H; Sui Y; Li H; Ma J; Guan J
    J Control Release; 2019 Oct; 311-312():233-244. PubMed ID: 31521744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration.
    Hosseinkhani H; Hosseinkhani M; Khademhosseini A; Kobayashi H; Tabata Y
    Biomaterials; 2006 Dec; 27(34):5836-44. PubMed ID: 16930687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor release from amylopectin hydrogel based on copper coordination.
    Tabata Y; Matsui Y; Ikada Y
    J Control Release; 1998 Dec; 56(1-3):135-48. PubMed ID: 9801437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.